Indigenous Vccine Technology

Acces sibility Controls

Implementing Organization

Project Overview

DBT-BIRAC-GCI supported Serum Institute of India for the first indigenously development of human papillomavirus vaccine (HPV)-- “CERVAVAC," against the cervical cancer in women

Related Research

View All

Quick Information

Area of Research

Life Sciences & Biotechnology

Focus Area

Vaccines, Infectious Diseases

Status

Currently availble in Indian Market

Output

No. of Research Paper

Technologies (If Any)

No. of PhD Produced

N/A

Startup (If Any)

No. of Patents

Filed :00

Grant :00